The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand,TRAIL, and Perforin/Granzyme B,Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model |
| |
| Authors: | Aswath P. Chandrasekar Nathan W. Cummins Sekar Natesampillai Anisha Misra Alecia Alto Greg Laird Andrew D. Badley |
| |
| Affiliation: | a Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA ; b Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA ; c Accelevir Diagnostics, Baltimore, Maryland, USA |
| |
| Abstract: | |
| |
| Keywords: | |
|
|
